Constitutive activation of mechanistic target of rapamycin complex 1 in the skeletal muscle of aged mice is sufficient to stimulate pro-inflammatory gene expression and elevate muscle tumor necrosis factor-alpha protein concentrations. In an investigation examining the downstream consequences of sustained anabolic signaling during biological senescence, researchers discovered that genetically ablating the DEP domain containing 5 gene in twenty-two-month-old female and male mice drove substantial inflammatory transcriptional reprogramming within muscle tissue by twenty-seven months of age. Although mechanistic target of rapamycin complex 1 activity naturally increases during physiological aging and has been linked to functional decline, directly enforcing its activity above baseline levels failed to accelerate muscle wasting, alter capillary density, or shift intramuscular macrophage infiltration. These findings demonstrate that elevated nutrient-sensing signaling can amplify molecular inflammatory cascades in aged skeletal muscle while remaining structurally uncoupled from widespread tissue remodeling or immediate fiber loss.
The mechanistic target of rapamycin complex 1 serves as an established intracellular regulator of cell growth, protein turnover, and metabolic homeostasis. Under ordinary physiological circumstances, muscular mTORC1 signaling oscillates dynamically, increasing during nutrient intake in the fed state and diminishing during fasting conditions. With advanced chronological age, however, basal skeletal muscle mTORC1 activity becomes chronically elevated, an alteration widely suspected of promoting muscle deterioration and inflammaging. While pharmacological inhibition using the compound rapamycin reliably extends overall lifespan and preserves healthspan across varied laboratory animal models, scientific understanding has remained limited regarding whether elevated mTORC1 signaling is independently sufficient to drive or worsen specific aging phenotypes. Prior genetic studies showed that deleting Depdc5, a critical structural component of the GATOR1 complex that suppresses mTORC1 in the absence of amino acids, produced muscular hypertrophy without improving physical endurance or functional contractile strength.
To determine how sustained mTORC1 activity alters the senescent muscular environment, investigators generated an inducible, skeletal muscle-specific knockout of Depdc5 in mice aged twenty-two months, a developmental stage known for heightened susceptibility to physiological decline and mortality. The experimental design included both male and female C57BL/6j animals to account for general biological variation. Gene deletion was initiated via intraperitoneal tamoxifen administration across five alternating days at seventy-five milligrams per kilogram, supplemented by an additional injection three days later and repeated monthly every twenty-eight days. The mice were then maintained for five months until reaching twenty-seven months of age. Throughout this period, cohorts of knockout mice were maintained either on standardized control rodent chow or on an experimental diet formulated with microencapsulated rapamycin at a concentration of fourteen parts per million to evaluate potential pharmacological reversal.
Western blot analyzes conducted on quadriceps muscle homogenates confirmed that Depdc5 knockout successfully hyperactivated downstream mTORC1 signaling pathways in the aged animals. Compared to wild-type control tissues normalized to Ponceau S total protein staining, muscles from knockout mice exhibited significant increases in the phosphorylation of downstream target proteins, including ribosomal protein S6 and 4E-BP1. Supplementation with dietary rapamycin at fourteen parts per million partially suppressed these elevated signaling cascades, restoring S6 phosphorylation while failing to reduce phospho-4E-BP1 at threonine thirty-seven and forty-six. The researchers also tracked key autophagy regulatory proteins, identifying altered expression patterns among markers such as p62, Parkin, Beclin-1, and phosphorylated ULK1 following gene deletion, which were partially attenuated by the five-month rapamycin intervention, confirming that the genetic model altered targeted intracellular proteostatic pathways.
Despite sustained biochemical activation of the mTORC1 pathway over the five-month experimental duration, hindlimb muscular dimensions remained largely unchanged between experimental groups. Dissections and wet weight measurements of the soleus, plantaris, gastrocnemius, and tibialis anterior muscles revealed no statistically significant mass differences across the wild-type, knockout, and rapamycin-treated cohorts under one-way analysis of variance. A minor statistically significant alteration was detected only within the extensor digitorum longus, where post hoc testing identified a modest difference between wild-type animals and rapamycin-treated knockouts. Repeated-measures evaluations across all sampled hindlimb muscles approached statistical significance with an overall p-value of 0.067. These phenotypic observations indicate that sustained nutrient-signaling pathway activation in already senescent muscle tissue does not trigger marked muscular hypertrophy or induce accelerated tissue atrophy over an extended five-month course.
Transcriptomic sequencing carried out on total ribonucleic acid extracted from gastrocnemius muscles uncovered extensive transcriptional divergence between wild-type and knockout animals. DESeq2 differential expression modeling, adjusted for sex as an analytical covariate, identified two hundred and thirty-eight genes with significant expression alterations resulting from Depdc5 deletion. When knockout mice received dietary rapamycin, eighty-nine of these altered transcriptional targets underwent expression reversal toward wild-type levels. Gene Set Enrichment Analysis showed that Depdc5 deletion substantially upregulated transcriptional programs dedicated to immune function, leukocyte activation, and inflammatory responses, paralleling patterns previously observed in younger nine-month-old knockout cohorts. Furthermore, the genetic deletion downregulated transcripts involved in angiogenesis and vascular development, showing that nutrient pathway hyperactivation broadly modifies transcript expression programs related to tissue vascularization and defense signaling.
Protein evaluations indicated that this enhanced inflammatory transcriptional activity corresponded to specific changes in circulating cytokine abundance within muscle beds. Western blot quantification demonstrated a statistically significant increase in total tumor necrosis factor-alpha in Depdc5 knockout muscle tissue, alongside an apparent increase in the seventeen-kilodalton cleaved form that acts as the actively secreted inflammatory signaling cytokine. Notably, dietary rapamycin administration failed to reverse this elevation in muscle tumor necrosis factor-alpha. In contrast, interleukin-6 protein levels showed notable animal-to-animal variability without achieving statistically significant divergence between groups. Messenger RNA measurements for both Il6 and Tnf exhibited no significant differences between experimental conditions, indicating that the observed accumulation of mature tumor necrosis factor-alpha protein in the aged knockout muscle is governed primarily through post-transcriptional mechanisms rather than direct de novo transcript generation.
To establish whether elevated cytokine expression induced cellular immune recruitment, researchers performed detailed immunohistochemical analyzes on frozen tibialis anterior muscle cryosections. Macrophage presence was evaluated using rat anti-mouse F4/80 antibodies to label total macrophage populations, alongside goat anti-CD206 antibodies to detect M2-like polarization states relative to individual myofiber counts. Surprisingly, neither total macrophage counts nor the proportion of CD206-positive M2 macrophages changed following Depdc5 knockout or rapamycin therapy, contrasting with prior findings in nine-month-old mice where knockout caused an M2 polarization shift. Similarly, capillary visualization using CD31 and wheat germ agglutinin revealed that despite significant reductions in angiogenic transcripts such as Pecam1, capillary density per square micrometer and capillary-to-fiber ratios remained unchanged, indicating that transcriptional vascular suppression does not rapidly degrade structural capillary networks in aged skeletal muscle.
To evaluate whether comparable inflammatory transcriptional patterns occur during primate aging and respond to mTORC1 inhibition, the researchers analyzed hindlimb skeletal muscle transcriptomes from young and aged common marmosets. The non-human primate cohort comprised young control animals averaging 4.2 years of age alongside twelve-year-old aged animals, half of which received oral rapamycin at approximately one milligram per kilogram five days per week mixed into yogurt. Differential expression profiling aligned to the Callithrix jacchus genome demonstrated that chronological aging in marmosets was naturally characterized by increased expression of pathways governing inflammatory signaling and immune response pathways. Chronic rapamycin administration significantly suppressed these age-associated inflammatory expression signatures in the primates, providing evidence that pharmacological inhibition of mTORC1 can temper transcriptomic inflammatory upregulation in normally aging primate muscle tissue.
The study authors highlighted several methodological limitations that frame the interpretation of their experimental findings. First, while rapamycin modulated S6 phosphorylation, it failed to suppress 4E-BP1 phosphorylation, leaving open the question of whether complete downstream signaling inhibition might achieve broader anti-inflammatory efficacy. Second, the reliance on F4/80 and CD206 immunohistochemical surface markers captures broad macrophage populations but cannot detect subtle functional shifts or minor immune subsets. Third, although male and female mice were examined, the sample size was not powered to resolve potential sex-specific divergence. Crucially, because functional contractile force, grip strength, and physical endurance were not recorded, the study could not assess whether the induced inflammatory environment impaired muscle quality. Future investigations comparing young and aged knockout cohorts under identical settings will be required to disentangle direct chronological aging effects from genotype-induced adaptations.
Subject of Research: Skeletal muscle mTORC1 activation and inflammatory gene expression in aged animal models
Article Title: Constitutive Activation of Skeletal Muscle mTORC1 Drives Pro‐Inflammatory Gene Expression in Skeletal Muscle of Aged Mice
Article References: Marchant, E. D., Kalenta, H., May, J., Lai, Z., Salmon, A. B., & Rasmussen, B. B. (2026). Constitutive Activation of Skeletal Muscle mTORC1 Drives Pro‐Inflammatory Gene Expression in Skeletal Muscle of Aged Mice. Aging Cell, 25(11), Article e70805. https://doi.org/10.1111/acel.70805
Image Credits: AI Generated
DOI: 10.1111/acel.70805
Keywords: Skeletal Muscle, mTORC1 Signaling, Inflammaging, Depdc5 Knockout, Rapamycin, TNF-alpha, Aging Research, Gene Expression, Constitutive, Activation, Skeletal, Muscle
News Source: Juliet Wilcox. (November 9, 2026). Sustained mTORC1 Activation Drives Pro-Inflammatory Gene Expression in Aged Mouse Muscle. Scienmag.



